Cytokinetics, Incorporated (CYTK)

Cytokinetics Revenue

Cytokinetics had revenue of $463.00K in the quarter ending September 30, 2024, with 22.49% growth. This brings the company's revenue in the last twelve months to $3.22M, down -58.81% year-over-year. In the year 2023, Cytokinetics had annual revenue of $7.53M, down -92.04%.

• Revenue (ttm): $3.22M
• Revenue Growth: -58.81%
• P/S Ratio: n/a
• Revenue / Employee: $7,610
• Employees: 423
• Market Cap: 5.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.53M	-87.06M	-92.04%
Dec 31, 2022	94.59M	24.16M	34.30%
Dec 31, 2021	70.43M	14.60M	26.15%
Dec 31, 2020	55.83M	28.96M	107.79%
Dec 31, 2019	26.87M	-4.63M	-14.71%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.